Drug Type Recombinant polypeptide |
Synonyms GLP-1-PEG, LY 2428757, LY-2428757 + [1] |
Target |
Mechanism GLP-1R agonists(Glucagon-like peptide 1 receptor agonists) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhaseDiscontinuedPhase 2 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Diabetes Mellitus, Type 2 | Phase 2 | US | 01 Dec 2008 | |
Diabetes Mellitus, Type 2 | Phase 2 | AT | 01 Dec 2008 | |
Diabetes Mellitus, Type 2 | Phase 2 | DE | 01 Dec 2008 | |
Diabetes Mellitus, Type 2 | Phase 2 | IN | 01 Dec 2008 | |
Diabetes Mellitus, Type 2 | Phase 2 | MX | 01 Dec 2008 | |
Diabetes Mellitus, Type 2 | Phase 2 | PR | 01 Dec 2008 | |
Diabetes Mellitus, Type 2 | Phase 2 | RO | 01 Dec 2008 | |
Diabetes Mellitus, Type 2 | Phase 2 | ZA | 01 Dec 2008 | |
Diabetes Mellitus, Type 2 | Phase 2 | ES | 01 Dec 2008 | |
Diabetes Mellitus, Type 2 | Phase 2 | UA | 01 Dec 2008 |
Phase 1 | 131 | nktnxokyiv(phdtwghgrg) = pknlizphpl izlvagnviy (yjxzxlawky, mfivaseiba - mesaiiikkp) View more | - | 13 Apr 2012 | |||
Phase 2 | 247 | (0.5 mg LY2428757) | ttuhebzyry(dsppwwobqs) = eruyowlplg lqtcydvsbu (mqnxjzxazm, bwnzxdqioh - lalsjjxggi) View more | - | 15 Jun 2011 | ||
(2.0 mg LY2428757) | ttuhebzyry(dsppwwobqs) = qcokpvawpq lqtcydvsbu (mqnxjzxazm, otyrmmooho - exuadckstk) View more |